| Focus group | Importance questionnaire | Experience questionaire | |||
---|---|---|---|---|---|---|
 | N | % | N | % | N | % |
Age (years): | Â | Â | Â | Â | Â | Â |
18-24 | 0 | 0 | 3 | 0.9 | 2 | 0.2 |
25-34 | 1 | 4.2 | 1 | 0.3 | 9 | 1.2 |
35-44 | 1 | 4.2 | 13 | 4.1 | 32 | 4.4 |
45-54 | 9 | 37.5 | 38 | 11.8 | 89 | 12.3 |
55-64 | 9 | 37.5 | 81 | 25.2 | 204 | 28.1 |
65-74 | 3 | 12.5 | 113 | 35.2 | 227 | 31.3 |
75 or older | 1 | 4.2 | 72 | 22.4 | 163 | 22.5 |
Gender: | Â | Â | Â | Â | Â | Â |
male | 8 | 33.3 | 167 | 52.0 | 333 | 46.1 |
female | 16 | 66.7 | 154 | 48.0 | 389 | 53.9 |
Highest education: | Â | Â | Â | Â | Â | Â |
none | 0 | 0 | 7 | 2.3 | 11 | 1.6 |
Primary education (1) | 0 | 0 | 26 | 8.5 | 59 | 8.4 |
Lower secondary education (2) | 1 | 4.2 | 63 | 20.7 | 158 | 22.4 |
Upper secondary education (3) | 1 | 4.2 | 64 | 21.0 | 167 | 23.7 |
Post-secondary non-tertiary education (4) | 3 | 12.5 | 37 | 12.1 | 85 | 12.1 |
Short cycle tertiary education (5) | 5 | 20.8 | 27 | 8.9 | 69 | 9.8 |
Bachelor (6) | 7 | 29.2 | 59 | 19.3 | 111 | 15.8 |
Master/Doctoral (7 or higher) | 7 | 29.2 | 21 | 6.9 | 32 | 4.6 |
Experienced health: | Â | Â | Â | Â | Â | Â |
excellent | 2 | 11.1 | 18 | 5.7 | 46 | 6.4 |
very good | 3 | 16.7 | 57 | 18.0 | 102 | 14.2 |
good | 6 | 33.3 | 172 | 54.3 | 367 | 51.0 |
reasonable | 7 | 38.9 | 54 | 17.0 | 169 | 23.47 |
poor | 0 | 0 | 16 | 5.1 | 36 | 5.0 |
Tumour type (more than 1 answer possible) | Â | Â | total 408 | Â | total 732 | Â |
Digestive tract | 6 | 17.1 | 58 | 14.2 | 205 | 28 |
Lower respiratory tract | 3 | 8.6 | 61 | 15.0 | 67 | 9.2 |
Breast | 9 | 25.7 | 45 | 11.0 | 171 | 23.3 |
Male reproductive organs | 1 | 2.9 | 79 | 19.4 | 153 | 20.9 |
Skin | 1 | 2.9 | 43 | 10.5 | 70 | 9.6 |
Blood, bone marrow and lymph nodes | 7 | 20.0 | 29 | 7.1 | 45 | 6.1 |
Urinary tract | 2 | 5.7 | 13 | 3.2 | 9 | 1.2 |
Female reproductive organs | 3 | 8.6 | 16 | 3.9 | 73 | 10.0 |
Head and neck | 1 | 2.9 | 16 | 3.9 | 4 | 0.5 |
Central nervous system | Â | Â | 0 | 0 | 2 | 0.3 |
Bone or soft tissue | Â | Â | 4 | 1.0 | 12 | 1.6 |
Endocrine glands | 1 | 2.9 | 3 | 0.7 | 4 | 0.5 |
Eye and orbit | 1 | 2.9 | 2 | 0.5 | 3 | 0.4 |
Treatment received (more than 1 answer possible) | ||||||
surgery | 21 | 45.7 | 230 | 44.6 | 492 | 46.9 |
chemotherapy | 11 | 23.9 | 115 | 22.3 | 141 | 13.4 |
radiotherapy | 12 | 26.1 | 125 | 24.2 | 257 | 24.5 |
hormone treatment | 2 | 4.3 | 44 | 8.5 | 127 | 12.1 |
immune therapy | Â | Â | 2 | 0.4 | 32 | 3.1 |
Treating specialist | Â | Â | Â | Â | Â | Â |
surgeon | 13 | 19.7 | Â | Â | Â | Â |
medical specialist/oncologist | 13 | 19.7 | Â | Â | Â | Â |
radiologist/radiotherapist | 8 | 12.1 | Â | Â | Â | Â |
oncology nurse | 5 | 7.6 | Â | Â | Â | Â |
nurse practitioner | 3 | 4.5 | Â | Â | Â | Â |
psychologist/social worker | 6 | 9.1 | Â | Â | Â | Â |
general practitioner | 12 | 18.2 | Â | Â | Â | Â |
physical therapist | 2 | 3.0 | Â | Â | Â | Â |
dietitian | 3 | 4.5 | Â | Â | Â | Â |
dermatologist | 1 | 1.5 | Â | Â | Â | Â |
Stage of treatment | Â | Â | Â | Â | Â | Â |
tests to acertain diagnosis | Â | Â | 4 | 1.3 | 13 | 1.9 |
diagnosis known, treatment starts | Â | Â | 4 | 1.3 | 8 | 1.2 |
during treatment | Â | Â | 68 | 22.2 | 158 | 22.9 |
no further treatment possible | Â | Â | 7 | 2.3 | 14 | 2.0 |
non-curative treatment | Â | Â | 31 | 10.1 | 69 | 10.0 |
checks after treatment | Â | Â | 168 | 54.9 | 374 | 54.1 |
treatment and checks after treatment are finished | Â | Â | 15 | 4.9 | 42 | 6.1 |
I don’t know (anymore) |  |  | 9 | 2.9 | 13 | 1.9 |